How much does a course of Nivolumab cost to treat melanoma?

Nivolumab (Nivolumab) is an immunotherapy used to treat many cancer types, including melanoma, and is designed to help turn on the immune system to help fight cancer. The optimal duration of treatment with nivolumab after complete remission is unclear, but it is not a drug that patients can continue taking indefinitely.

In clinical studies of nivolumab, treated melanoma patients generally had durable responses after stopping treatment, receiving treatment for a median duration of 7 months to achieve a complete response - defined as the disappearance of all signs of cancer responding to treatment, with a 72.1% probability of being alive without further treatment for their melanoma after 3 years. After maintaining complete remission for 1 year, patients had an 83.3% chance of maintaining complete remission for 2 years or longer. According to the prescribing information, the recommended dose of nivolumab (as a single agent) is 240 mg intravenously over 30 minutes every 2 weeks or 480 mg intravenously over 30 minutes every 4 weeks until disease progression or unacceptable toxicity.

The generic drug Nivolumab is currently on the market in China, but it has not yet been included in medical insurance. This drug is a strictly controlled drug, and its purchase channels are restricted. Specifications The price of each box of 40mg/4ml may be around 4,000 yuan, and the price of each box of 100mg/10ml may be around 7,000 yuan. The price of a course of treatment may be tens of thousands of yuan, which is expensive. The Turkish version of the nivolumab generic drug listed overseas may cost more than RMB 2,000 per box of 40mg/4ml (the price may fluctuate due to exchange rates). Currently, there is no generic version of nivolumab available on the market. For more drug information and specific prices, please consult a medical consultant.